Clinical Trial Update: Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for a Phase 2/Phase 3 study evaluating plasmatic levels of busulfan in patients undergoing hematopoietic stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunodeficiency Disorders
• Leukemia
• Lymphoproliferative Disorders
• Myeloproliferative Disorders

Drugs mentioned

• BUSULFAN (Busulfan)

Snippet

Sponsor: Hospital Israelita Albert Einstein | Conditions: Acute Leukemia, Chronic Leukemia | Phase 2, Phase 3 | Status: UNKNOWN